Search

everythinglearnresearchcommunity

for

Search:↓

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The niosomes effectively target hair follicles for acne treatment.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

A patient with complete hair loss regrew all her hair using tofacitinib.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

A long-term pubic rash was finally diagnosed as white piedra and cured with ketoconazole.

Mutations in the P2RY5 gene cause hereditary woolly hair.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

JAK inhibitors may help improve symptoms in adults with APECED.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.